Calif. Drug Ruling Affirms Defect-Centric Liability Framework
In a long-awaited decision in Gilead Tenofovir Cases, the California Supreme Court held this week that drug manufacturers do not owe a duty of care to users of a nondefective drug...To view the full article, register now.
Already a subscriber? Click here to view full article